Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis

Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis

Background: Stratifying prostate cancer (PCa) patients into risk groups at time of initial diagnosis enabling a risk-adapted disease management is still a major clinical challenge. Existing studies evaluating the prognostic potential of PSMA (prostate-specific membrane antigen) for PCa were performe...

Full description

Bibliographic Details
Main Authors: Marie Christine Hupe, Christian Philippi, Doris Roth, Christiane Kümpers, Julika Ribbat-Idel, Finn Becker, Vincent Joerg, Stefan Duensing, Verena Helena Lubczyk, Jutta Kirfel, Verena Sailer, Rainer Kuefer, Axel Stuart Merseburger, Sven Perner, Anne Offermann
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-12-01
Series:Frontiers in Oncology
Subjects:
disease recurrence
immunohistochemistry
prognostic biomarker
prostate biopsy
prostate cancer
prostate-specific membrane antigen
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2018.00623/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2018.00623/full

Similar Items